Skip Navigation Links
   
Skip Navigation Links
   

GU - Transitional Cell (Urinary Tract - renal pelvis, ureter, bladder, prostate, or urethra)

Transitional Cell Cancer at CCOP Cancer Research St. Louis, MO

MATCH: Molecular analysis for therapy choice. Targeted therapy directed by genetic testing in treating patients with advanced refractory solid tumors or lymphoma.  EAY131 (NCT02465050)  (MBMC Contact: Missy Kuhn 314-996-5868)  

A prospective phase II trial of neoadjuvant systemic chemotherapy followed by extirpartive surgery for patients with high grade upper tract urothelial carcinoma  ECOG-ACRIN EA8141 (NCT02412670) (MBMC Contact:  Missy Kuhn 314-996-5868)  ARM A closed 5/1/17

Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer  S1605 (NCT02844816)  (MBMC Contact:  Chris Sanders 314-996-5802) 

 

A randomized phase II study of CO-eXpresssion (COXEN) with neoadjuvant chemotherapy for localized, muscle-invasive bladder cancer  SWOG S1314 (NCT02177695)  (MBMC Contact:  Missy Kuhn 314-996-5868)

 

 

 

 

 

 

 

 
 

All contents 2007 Heartland Cancer Research St. Louis, MO. All rights reserved. Privacy Policy